Among one of the first hospitals in the nation to see COVID-19 patients, El Camino Health and the Taft Center for Clinical Research has been among the leaders in COVID-19 clinical trials, working with pharmaceutical companies to find solutions to help manage and cure the deadly pandemic.
El Camino Health administered its first COVID-19 vaccinations to hospital front-line workers and physicians on December 18, and, by the end of the year, more than 1,600 employees and travelers, and close to 400 physicians, have received the first in a series of two vaccinations.
Thorough preparation and the ability to be flexible and agile, when necessary, is helping El Camino Health’s Emergency Department and Critical Care Unit continue to provide high quality care as the number of COVID-19 patients and overall patient volume continued to grow through November and December.
As the Environmental Health and Safety Manager for El Camino Health, preparing for emergencies, large or small, is a routine part of the job for Steve Weirauch.
Los Altos Hills philanthropists Pamela and Edward Taft have made a gift to support nurse engagement in quality improvement science, research, and investigative work over the next five years.
975 doses of the new Pfizer-BioNTech vaccine will be administered; infectious disease specialist who treated the first confirmed case of community spread in Bay Area among first to receive
Bloom Energy and El Camino Health today announced the launch of the University of Illinois’ innovative Shield T3 COVID testing system and mobile laboratory at Bloom Energy’s manufacturing facility in Sunnyvale, California.
